Literature DB >> 30137243

Another New Antibiotic for Skin Infections and Why Infectious Disease Specialists Are Hypocrites.

Loren G Miller1,2.   

Abstract

Entities:  

Year:  2019        PMID： 30137243     DOI： 10.1093/cid/ciy720

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.

Authors:  T D Trinh; S C J Jorgensen; E J Zasowski; K C Claeys; A M Lagnf; S J Estrada; D J Delaportes; V Huang; K P Klinker; K S Kaye; S L Davis; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 2.  It's about the patients: Practical antibiotic stewardship in outpatient settings in the United States.

Authors:  Alpesh N Amin; E Patchen Dellinger; Glenn Harnett; Bryan D Kraft; Kerry L LaPlante; Frank LoVecchio; James A McKinnell; Glenn Tillotson; Salisia Valentine
Journal:  Front Med (Lausanne)       Date:  2022-07-27

Review 3.  The Intersection of Antimicrobial Stewardship, the Pharmaceutical Industry, and the Federal Legislature.

Authors:  Eric Gregory; Craig Martin
Journal:  Open Forum Infect Dis       Date:  2022-08-05       Impact factor: 4.423

4.  Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid.

Authors:  Frederick Wittke; Catherine Vincent; James Chen; Barry Heller; Heidi Kabler; J Scott Overcash; François Leylavergne; Guennaëlle Dieppois
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.